Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenzo O Palmieri

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Annals of Hepatology|July 29, 2004
Overview on the mechanisms of drug-induced liver cell deathIgnazio Grattagliano, Piero Portincasa, Vincenzo O Palmieri, et al.
Hepatology (Baltimore, Md.)|January 30, 2007
Mutual changes of thioredoxin and nitrosothiols during biliary cirrhosis: results from humans and cholestatic ratsIgnazio Grattagliano, Piero Portincasa, Vincenzo O Palmieri, et al.
Current Medicinal Chemistry|November 1, 2006
Current pharmacological treatment of nonalcoholic fatty liverPiero Portincasa, Ignazio Grattagliano, Vincenzo O Palmieri, et al.
The Annals of Pharmacotherapy|August 3, 2006
Adefovir dipivoxyl for the treatment of delta-related liver cirrhosisIgnazio Grattagliano, Vincenzo O Palmieri, Piero Portincasa, et al.
The Journal of Nutrition|November 23, 2006
Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndromeVincenzo O Palmieri, Ignazio Grattagliano, Piero Portincasa, et al.
Clinical Biochemistry|February 15, 2005
Nonalcoholic steatohepatitis: recent advances from experimental models to clinical managementPiero Portincasa, Ignazio Grattagliano, Vincenzo O Palmieri, et al.
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|August 11, 2005
Contribution of canalicular glutathione efflux to bile formation. From cholestasis associated alterations to pharmacological intervention to modify bile flowIgnazio Grattagliano, Piero Portincasa, Vincenzo O Palmieri, et al.
Canadian Family Physician Medecin De Famille Canadien|September 18, 2007
Managing nonalcoholic fatty liver disease: recommendations for family physiciansIgnazio Grattagliano, Piero Portincasa, Vincenzo O Palmieri, et al.
Romanian Journal of Gastroenterology|April 1, 2005
The emerging problem of nonalcoholic steatohepatitis (NASH)Piero Portincasa, Ignazio Grattagliano, Vincenzo O Palmieri, et al.
Clinical Biochemistry|October 4, 2011
Long-term ursodeoxycholate improves circulating redox changes in primary biliary cirrhotic patientsIgnazio Grattagliano, Vincenzo O Palmieri, Piero Portincasa, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Annals of Hepatology|July 29, 2004
Overview on the mechanisms of drug-induced liver cell deathIgnazio Grattagliano, Piero Portincasa, Vincenzo O Palmieri, et al.
Hepatology (Baltimore, Md.)|January 30, 2007
Mutual changes of thioredoxin and nitrosothiols during biliary cirrhosis: results from humans and cholestatic ratsIgnazio Grattagliano, Piero Portincasa, Vincenzo O Palmieri, et al.
Current Medicinal Chemistry|November 1, 2006
Current pharmacological treatment of nonalcoholic fatty liverPiero Portincasa, Ignazio Grattagliano, Vincenzo O Palmieri, et al.
The Annals of Pharmacotherapy|August 3, 2006
Adefovir dipivoxyl for the treatment of delta-related liver cirrhosisIgnazio Grattagliano, Vincenzo O Palmieri, Piero Portincasa, et al.
The Journal of Nutrition|November 23, 2006
Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndromeVincenzo O Palmieri, Ignazio Grattagliano, Piero Portincasa, et al.
Clinical Biochemistry|February 15, 2005
Nonalcoholic steatohepatitis: recent advances from experimental models to clinical managementPiero Portincasa, Ignazio Grattagliano, Vincenzo O Palmieri, et al.
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|August 11, 2005
Contribution of canalicular glutathione efflux to bile formation. From cholestasis associated alterations to pharmacological intervention to modify bile flowIgnazio Grattagliano, Piero Portincasa, Vincenzo O Palmieri, et al.
Canadian Family Physician Medecin De Famille Canadien|September 18, 2007
Managing nonalcoholic fatty liver disease: recommendations for family physiciansIgnazio Grattagliano, Piero Portincasa, Vincenzo O Palmieri, et al.
Romanian Journal of Gastroenterology|April 1, 2005
The emerging problem of nonalcoholic steatohepatitis (NASH)Piero Portincasa, Ignazio Grattagliano, Vincenzo O Palmieri, et al.
Clinical Biochemistry|October 4, 2011
Long-term ursodeoxycholate improves circulating redox changes in primary biliary cirrhotic patientsIgnazio Grattagliano, Vincenzo O Palmieri, Piero Portincasa, et al.
Pageof 4